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Abstract
Objectives We report a preclinical comparative study of a
96-strand braided flow diverter.
Methods The 96-strand braided device was compared with
the currently commercially available flow diverter with 48
strands. The devices were implanted across the neck of 12
elastase-induced aneurysms in New Zealand White rabbits
and followed for 1 and 3 months (n=6 respectively). Aneu-
rysm occlusion rates, parent artery stenosis and patency of
jailed branch occlusions were assessed by angiography, his-
tology and scanning electron microscopy studies.
Results It was feasible to navigate and implant the 96-strand
device over the aneurysm orifice in all cases. At follow-up
two aneurysms in the 48-strand vs. one in the 96-strand
group were not occluded. This aneurysm from the 96-
strand group however had a tracheal branch arising from
the sac and showed a reverse remodelling of the vascular
pouch at 3 months. In the occluded aneurysms, the parent
artery was always completely reconstructed and the aneu-
rysm orifice was sealed with neointimal tissue. No in-stent
stenosis or jailed branch artery occlusion was observed.
Conclusions The 96-strand flow diverter proved to be safe,
biocompatible and haemodynamically effective, induced sta-
ble occlusion of aneurysms and led to reverse remodelling of
the parent artery.
Key points
• Flow diversion has been introduced to improve endovascular
treatment of cerebral aneurysms
• A new low-permeability flow diverter is feasible for parent
artery reconstruction.
• The Silk 96 flow diverter appears effective at inducing
aneurysm healing.
• The covered branches remained patent at follow-up.
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Abbreviations
CCA Common carotid artery
DSA Digital subtracted angiography
FD Flow diverter
PA Parent artery
SEM Scanning electron microscopy
VA Vertebral artery
Introduction
The concept of flow diversion was introduced to im-
prove endovascular methods for the treatment of cere-
bral aneurysms with larger segmental wall defects of the
parent artery. In vitro and in vivo studies have demon-
strated that stents with different porosity and pore den-
sity properties have a variety of interesting effects on
intra-aneurysmal haemodynamics [1–4]. This led to the
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introduction of the flow diversion concept: a single
endovascular, stent-like device, positioned across the
aneurysm orifice will redirect blood flow to the parent
artery and thus induce thrombosis of the aneurysm,
whilst maintaining patency of adjacent branching vessels
covered by the device.
The currently available flow diverter devices for in-
tracranial aneurysm treatment have shown very promis-
ing results in parent vessel reconstruction and aneurysm
healing in the clinical setting. These devices are braided
structure tubular constructs, composed of a mesh of
very fine strands. In clinical practice, data are available
on the effectiveness of the Silk and the PED, both with
a 48-wire braided structure. These data show that al-
though the occlusion rate of treated aneurysms progres-
sively increases over time, at 6 months it is approxi-
mately 76 % [5]. During the process of thrombosis the
treated aneurysms may be unprotected from rupture, or in very
large and giant lesions, the risk of rupture after treatment may
even increase, likely by an inflammatory aneurysm wall reac-
tion mediated by the quality of the induced intra-aneurysmal
thrombus [6, 7]. When it comes to increasing occlusion rates,
augmenting the haemodynamic power of flow diverters may
theoretically allow this goal to be achieved.
Therefore, our purpose was to analyse the feasibility and
effectiveness of a new-generation, higher braid profile flow
diverter device with altered porosity and pore density prop-
erties in the treatment of experimentally created aneurysms
in a rabbit model.
Materials and methods
Flow diversion devices
In this comparative study the products tested were braided
flow diverter devices with different porosity and pore density
properties. The basis device used was the Silk, which is a
commercially available 48-wire braided mesh cylinder
(called Silk 48 in this study) composed of a nickel-titanium
(NiTinol) alloy and platinum microfilaments. Silk received
the CE mark in January 2008. The study device was the Silk
96, a new-generation flow diverter with double the wire
count of the original Silk. The Silk 96 presents with altered
porosity, pore density and permeability properties, as shown
in Table 1. Both are flexible, self-expanding devices specif-
ically designed for parent artery reconstruction and aneu-
rysm thrombosis.
Animal experiments
The ethics committee of the responsible Veterinary Authority
approved all experimental protocols. Animals underwent
two surgical procedures under general anaesthesia at two
different time points: aneurysm induction and FD implanta-
tion. Twelve New Zealand White female rabbits were allo-
cated to one of two similar study groups (six animals in each)
according to the type of implanted device (Silk 48 or Silk
96). Each group was further divided into two subgroups
according to the follow-up time, i.e. 4 weeks and 12 weeks
following the FD implantation, respectively.
Aneurysms were created according to the established
elastase-induced aneurysm model [8]. Briefly summarised,
under general anaesthesia, under sterile conditions, the right
common carotid artery (CCA) of the animal was surgically
isolated. An arteriotomy of 1–2 mm was made and a 5 F
introducer sheath was advanced into the CCA in a retrograde
fashion. Through the introducer sheath a 15-cm long
microtube and a 2 F Fogarty balloon catheter were intro-
duced. For elastase injection a microtube was used instead of
a regular microcatheter, providing a much smaller dead
space in the delivery system. The balloon was inflated at
the origin of the right CCA and a seal test was performed by
injection of contrast material. Keeping the balloon inflated,
with the tip of the microtube close to the proximal end of the
balloon, a mixture of 100 units of porcine pancreatic elastase
(Worthington Biochemical Corp.), contrast material and sa-
line solution at a ratio of 2:1:1 respectively was infused into
the lumen of the isolated CCA segment and allowed to
incubate for 20 min. At the end of the incubation period the
stump was flushed with saline, and the balloon and microtube
were removed. A control angiography was performed and the
CCAwas ligated permanently at the level of the arteriotomy.
The flow diversion treatment of the induced aneurysm
was planned at a minimum maturation period of 3 weeks
after aneurysm induction. Starting 2 days before FD implan-
tation the animals were premedicated with aspirin (10 mg/kg
PO) and clopidogrel (10 mg/kg PO); this regimen was con-
tinued for 4 weeks after endovascular treatment. Under gen-
eral anaesthesia, the right femoral artery was surgically iso-
lated and a 5 F introducer sheath was gently inserted. Ani-
mals were anticoagulated with 50 IU/kg of unfractionated IV
heparin. Through a 5 F guiding catheter, the FD delivery
Table 1 Porosity, pore density and permeability data of flow diverters
used in the study. The data are calculated for nominal 3.5-mm-diameter
devices, unconstrained to a 3.75-mm diameter size (data provided by
the manufacturer). The permeability of the devices was calculated
according to the previously published formula [2]
Silk 48 Silk 96
Mean strand size 0.034 mm 0.029 mm
Porosity 77 % 65 %
Pore density 12 pores/mm2 40 pores/ mm2
Permeability 178 μm2 74 μm2
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microcatheter, a Vasco 21 for the Silk 48 and a Vasco 25
(Balt International, France) for the Silk 96, was placed over a
microguidewire in the subclavian artery. The FD was
deployed across the neck of the aneurysm, and, in cases
where the length of the device allowed, also covering the
orifice of the vertebral artery. At the end of the procedure, the
catheter and the introducer sheath were removed. The fem-
oral artery was permanently ligated.
Angiographic evaluation of aneurysm occlusion was
performed immediately following the FD implantation and
before killing the animals, according to the scale proposed by
Kamran et al. [9]:
0. No change in the endoaneurysmal flow;
1. Residual contrast medium filling more than 50 % of the
pre-treatment aneurysm volume;
2. Residual contrast medium filling less than 50 % of the
pretreatment aneurysm volume;
3. Residual filling confined to the neck region and not
extending beyond the width of the neck;
4. No residual filling, i.e. complete obliteration of the
aneurysm.
The incidence of parent artery stenosis was assessed at
sacrifice with angiography and with histology.
Animals were followed up at 4 and 12 weeks. Before
being killed, they were deeply sedated with IV propofol
infusion. An intra-venous DSA of the right subclavian artery
was performed by injecting a bolus of 12 ml of contrast agent
through the cannulated left ear vein, as described previously
[10]. Following angiography, a large dose of propofol was
administered. In the areactive animal, the neck was dissected
to open the large neck veins in order to exsanguinate the
animal. The chest wall was surgically opened and the left
ventricle of the heart was punctured. The left ventricle was
continuously flushed with approximately 800–1,000 ml
NaCl 0.9 % solution until the bleeding from the neck veins
showed only minimal blood staining. The aortic arch with
the supra-aortic trunks was then carefully dissected and fixed
in 4 % buffered formalin. The samples were stored at 4 °C
until histological preparation.
Tissue processing
Specimens were fixed in 4 % buffered formalin. After fixa-
tion the samples were rinsed in water and further dehydrated
in an ascending series of ethanol (50 %, 70 %, 80 %, 90 %
96 %, 100 %) before being placed in xylene under vacuum.
The infiltration of the samples proceeded under vacuum at
4 °C in methyl methacrylate. Embedding of specimens in
methyl methacrylate (Methacrylic acid methyl ester, Fluka
Chemie GmbH, Buchs, Switzerland; dibutyl phthalate, Merck-
Schuchardt OHG, Hohenbrunn, Germany; Perkadox 16, Dr.
Grogg Chemie AG, Stetten, Switzerland) was performed in
customised Teflon forms. After polymerisation, the blocks were
mounted on plastic frames and cut with a precision saw (Leica
SP 1600®, Leica Instruments GmbH, Nussloch, Germany).
Sections were mounted on acropal slides (Perspex GSAcrylglas
Opal 1013, Wachendorf AG, Basel, Switzerland) and polished
to 100– to 150-μm sections (Exakt® Mikroschleifsystem 400
CS, Exakt Apparatebau GmbH, Norderstett, Germany). Ground
sections were surface stained with Giemsa in order to carry out
the light microscopy. Neointimal thickness was measured as the
distance between the device and the lumen.
For SEM, tissue samples were fixed with 2.5 % glutaral-
dehyde (Fluka, Bornem, Belgium) and washed with
phosphate-buffered saline. The specimens were dehydrated
with graded series of ethanol followed by critical point drying.
The specimens were mounted and gold sputtered to achieve
the surface conductivity required for SEM. SEM was
performed on five samples (three Silk 48 and two Silk 96).
Histology and SEM analysis allowed for evaluation of
endothelial coverage of the implants, aneurysm occlusion
and intra-aneurysmal thrombosis.
Results
The rabbits in the two groups had similar ages and weights
(mean weight 4.3±0.7 kg). Mean size of the created aneu-
rysms was 3×6 mm with a mean neck size of 3 mm. Fol-
lowing implantation, the induced flow changes in the aneu-
rysms were evaluated by DSA. Slowing down of the intra-
aneurysmal flow after FD implantation as shown by in-
creased contrast material residence time was observed in all
except two cases, both from the Silk 48 group (Fig. 1).
Immediate aneurysm occlusion was observed in two cases,
one in each group. We observed no procedural thromboem-
bolic events, vessel dissection or other adverse events.
The anatomical distance between the aneurysm and the
vertebral artery did not allow for covering of the orifice of
the VA with the FD in all cases. This was achieved only in
three cases, all from the Silk 96 group, two from the 4-week
and one from the 12-week survival subgroup. In these cases
the VA remained patent both immediately after implantation
and at sacrifice.
Aneurysm occlusions at sacrifice
At the 4-week sacrifice all aneurysms from both the Silk 48
and Silk 96 groups showed complete (grade 4) occlusion. At
the 12-week sacrifice there were differences between the two
groups. In the Silk 48 group, there were two aneurysms
showing only partial thrombosis of approximately 30 %
(grade 1) and 80 % (grade 2) occlusion of the aneurysm
compared with its original size. In the Silk 96 group, there
was only one aneurysm showing persistent patency. In this
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case, the control angiogram demonstrated a tracheal branch
originating from the aneurysm itself. The saccular part of the
aneurysm was remodelled with reduction of the aneurysm
pouch size, and the tracheal branch was still filling. At 4 and
12 weeks there was no angiographically proven in-stent
stenosis or parent vessel occlusion in either group.
Histology and SEM evaluation
Twelve out of 12 samples were available for histology; the
remaining two samples were processed only for SEM. Both
the Silk 48 and Silk 96 groups were found to have induced
thrombus formation at 4 weeks after stent implantation. The
thrombus was organised and either layered or unstructured,
independent of the type of flow diverter used (Fig. 2). At
12 weeks histology sections were available in four of the 6
samples (2 from each group). In the Silk 48 group, the
partially occluded aneurysm showed a layered thrombus,
occupying approximately 50 % of the original aneurysm
volume. The second occluded aneurysm had shrunk and
showed intraluminal fibrous tissue formation. In the Silk 96
group one aneurysm showed complete remodelling, showing
only a fibrous transformation of the original carotid artery
wall. In the second sample the aneurysm was no longer
identified on the available sections, suggesting complete
shrinkage. All the occluded aneurysms showed neointimal
formation over the aneurysm neck.
Histology revealed a complete, uniform and similar
endothelialisation over the FD surface in both groups at both
follow-up time points, without signs of intimal hyperplasia
and with a maximal neointimal thickness of less than
200 μm. Complete and smooth neointimal coverage was
also proven by the SEM studies. In cases where the origin
of the branching vessels was covered by the device, the
strands of the FD were covered by endothelial cells and fine
fibrin-like structures; however the pores of the device
remained patent. The macroscopic and SEM studies also
demonstrated the partial coverage of the aneurysm orifice
by an endothelial layer in the aneurysms not occluded at
3 months (Fig. 3).
Discussion
In this study we describe the effectiveness results of a new-
generation, lower porosity and higher pore density, 96-strand
Fig. 1 a Digital subtraction angiography of the supra-aortic arteries of
a rabbit, demonstrating an elastase-induced, large neck aneurysm. b
Contrast material stagnation in the aneurysm after the implantation of a
Silk 96 device. c Follow-up i.v. angiography at 4 weeks, showing the
complete occlusion of the aneurysm, the patency of the subclavian
branches and no signs of in-stent stenosis
Fig. 2 a Homogeneous
(no layering) pattern of intra-
aneurysmal thrombus at 4 weeks.
b Thrombus showing a distinct
pattern of layering. Both
aneurysms were treated with a
Silk 96 device, but showed
different morphology, a possible
explanation for the difference in
thrombus nature
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braided flow diverter device in comparison to its commer-
cially available predecessor, the Silk FD, in an elastase-
induced rabbit aneurysm model. The new-generation FD
device proved to be feasible and effective in parent artery
reconstruction. The Silk 96 showed better performance in
inducing aneurysm occlusion and arterial wall reverse
remodelling.
Early in vitro studies revealed that stents are able to
change intra-aneurysmal haemodynamics when placed
across the orifice of aneurysms [1–4]. This flow-modifying
effect of conventional balloon expandable and self-
expanding stents is however usually not sufficient to induce
aneurysm occlusion if applied alone. Such stent use is mainly
to support endosaccular treatment. Meeting the clinical de-
mand for endovascular parent artery reconstruction in certain
aneurysm morphologies, the current technological advance-
ments in the manufacturing of neuroendovascular devices
led finally to the development of the currently available
braided flow diverters. Compared with conventional intra-
cranial stents, these FDs have a markedly lower porosity
(60–80 %; proportion of open area to total area of the stent).
Although they demonstrated great effectiveness especially in
the treatment of “difficult” aneurysms [11–18], the rate of
complete aneurysm occlusion at 6 months remains at 76 %
[5]. This suggests still insufficient flow diversion under
specific conditions. If flow diversion with a currently avail-
able device proves to be insufficient, a biologically active
clot may remain, causing an inflammatory status and thus not
allowing healing by reverse remodelling, or leading to aneu-
rysm rupture [6, 7]. Complementary treatment options in
such situations are limited to reducing or completely weav-
ing off antiplatelet therapy, adding another or more FDs or
occluding the parent artery—all options that require taking
additional risks and increasing costs. There is thus a well-
justified clinical need to increase the effectiveness of flow
diversion.
A pragmatic way of increasing the flow-modifying effect
across the aneurysm orifice is achieved in clinical practice by
implanting multiple devices in a coaxial or telescopic fash-
ion. Although there are no published results on the increased
effectiveness of this technique, it is usually performed to
amplify the flow-modifying effects of the flow diverter con-
struct [18]. Implanting multiple devices implies an elevated
technical complication risk and increased costs. Therefore, a
more elegant way would be to augment the flow-diverting
properties of a single device.
In vitro and in vivo studies demonstrated that the flow
modification power of a flow diverter device is defined by
both low- and high-pore density (defined as the number of
pores per area) [19–21]. A certain porosity of the device is
also required for persisting patency of the jailed side
branches. Decreasing porosity while maintaining or increas-
ing pore density will necessarily increase the amount of
material in the construct. This will result in a higher profile
of the squeezed device, reduced flexibility and the need for a
larger delivery microcatheter. These features may markedly
reduce the feasibility of such devices to be delivered to the
cerebral arteries and to treat cerebral aneurysms.
The Silk 96 has double the wire count of the commercially
available Silk and of the PED, both with the 48-strand
braided structure. The resulting porosity and permeability
are markedly reduced and the pore density increased. De-
spite the doubled number of wires, the device exhibits only a
slightly higher profile, requiring the use of a 0.025″ ID
microcatheter, and could be delivered and deployed at the
target site without technical difficulties (for comparison,
microcatheter IDs used: 0.021″ for Silk, 0.027″ for the
PED and 0.032–0.040″ for Surpass FD delivery). The new
device did not induce intimal hyperplasia or parent artery
occlusion in any of the cases. It proved to be more effective
at inducing aneurysm occlusion.
One interesting finding of our current study was the two
different, either “layered” or “homogeneous” thrombus struc-
tures at 4 weeks. The layered thrombus has alternative “red”
and “white” layers, whereas the “homogeneous” thrombus
shows no such distinct layering pattern. Microscopically, a
Fig. 3 Macrograph (a) and
scanning electron microscopy
picture (b) of the orifice of an
aneurysm treated with a Silk 48
device at 12 weeks following
implantation. The aneurysm
remained patent. Note the partial
endothelial coverage of the
orifice, with the central portion
not populated by the endothelial
layer, allowing for persisting
patency
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layered thrombus exhibits laminations known as “lines of
Zahn”. Two primary prerequisites of a “layered thrombus”
are that it is formed at a site of constant blood flow and that its
formation is episodic. The formation process signifies the
delicate balance between the thrombotic and thrombolytic
factors, influenced by the shear rate of the flowing blood
[22]. The pale portion of the thrombus consists of platelets
mixed with fibrin, whereas the darker layer consists of
entrapped red cells. Along the same context, “non-layered”
homogeneous thrombus is formed rather instantly owing to
the stagnation of blood. The close interaction between the
intra-luminal thrombus and the aneurysm wall has already
been demonstrated [23]. The quality and volume of intra-
aneurysmal thrombus play key roles in inducing aneurysm
healing or driving the aneurysm towards the so-called delayed
rupture phenomenon, seen in about 1–2 % of cases treated
with flow diversion alone [5–7]. The inflammatory reaction
and the oxidative stress induced by a large volume of cell-rich
clots may be overwhelming to the aneurysm wall, leading to
decellularisation and destruction, and finally to rupture [6].
We hypothesise, that a gradually developing thrombus, as
shown by the layered pattern, may have a less deleterious
effect on the aneurysm wall, by inducing a less important or
at least slower acting inflammatory reaction and oxidative
stress to the vessel aneurysm wall, eventually also allowing
for repair mechanisms. Owing to the applied histological
methodology, the thrombus aneurysm wall could not been
evaluated in this study.
Our study has several limitations. The relatively low
number of animals treated did not allow for assessing signif-
icant differences in induction of thrombosis and in the qual-
ity of intra-aneurysmal thrombus between the two different
devices. Second, the aneurysms treated in this series were
relatively small lesions, not necessarily reflecting the aneu-
rysms treated by flow diversion in the clinical practice. This
limitation is related to the animal model itself. The results
should therefore be interpreted accordingly.
In conclusion, in this elastase-induced rabbit aneurysm
model, the 96-strand braided flow diverter device, the Silk
96, proved to be safe and effective in parent artery recon-
struction and aneurysm healing. This new-generation device
with reduced porosity and permeability induced stable oc-
clusions and remodelling of the treated aneurysms, without
signs of neointimal hyperplasia, and without inducing occlu-
sion of the jailed side branches. This new design may be a
promising tool for treating cerebral aneurysms more effec-
tively and safely.
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